Hexadecenoic acid (cis-9)Hexadecenoic acid (cis-9)
Move your mouse over image or click to enlarge

Hexadecenoic acid (cis-9)

C16:1 (cis-9) Fatty acid; Palmitoleic acid

Hexadecenoic acid (cis-9) is often found as a component of human adipose tissues, esterified to glycerol and is found in small amounts in most animals. It is synthesized from palmitic acid by the enzyme delta-9-desaturase. Hexadecenoic acid (cis-9) is thought to be biomarker for the de novo synthesis of fatty acids from glucose. It has been reported that there is a consistant positive association between changes in inflammatory markers and hexadecenoic acid (cis-9). Hypercaloric high carbohydrate diets have been shown to stimulate the production of several fatty acids including hexadecenoic acid (cis-9) and its increase is a marker of lipogenesis.{50522} Hexadecenoic acid (cis-9), because it is a product of stearoyl-CoA desaturase activity, can be used as a biomarker for triglyceridemia and abdominal adiposity.{50523} It has been demonstrated that oleic and Hexadecenoic acids (cis-9) can inhibit the cytotoxic activity of trans-10, cis-12-conjugated linoleic acid.{50524} Hexadecenoic acid (cis-9) has been classified as a lipid hormone which stimulates insulin in muscles.{50525}
Cat# Size Price Qty Buy
1016 100 mg £71.40

Additional Information

Property Value or Rating
Product Size 100 mg
Manufacturer Matreya, LLC
Empirical Formula C16H30O2
CAS# 373-49-9
Formula Weight 254.4
Solvent none
Source natural
Purity 99%
Analytical Methods GC, TLC
Natural Source Plant/Macadamia
Solubility chloroform, hexane, ethyl ether
Physical Appearance A neat liquid
Storage -20°C

1. C. Forsythe “Comparison of Low Fat and Low Carbohydrate Dietson Circulating Fatty Acid Composition and Markers of Inflammation” Lipids, Vol. 43 pp. 65-77, 2008 
2. F. Paillard et al. “Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity” Nutrition, Metabolism, and Cardiovascular Diseases, Vol. 18(6) pp. 436-440, 2008 
3. M. Yamasaki et al. “Alleviation of the cytotoxic activity induced by trans10, cis-12-conjugated linoleic acid in rat hepatoma dRLh-84 cells by oleic or palmitoleic acid” Cancer Letters, Vol. 196(2) pp. 187-196, 2003 
4. Z. Yang, H. Miyahara, A. Hatanaka “Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes” Lipids in Health and Disease, vol. 10 pp. 120, 2011

Related Documents